Dr. Roy M Bartee Ii, Anesthesiology Medicare: Medicare Enrolled Practice Location: 6287 S Coventry Ln W, Littleton, CO 80123 Phone: 303-795-2205 |
Dr. Brian J Hopkins, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3 Larkdale Dr, Littleton, CO 80123 Phone: 303-422-9438 |
Mrs. Beth Marie Katubig, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7880 Galileo Way, Littleton, CO 80125 Phone: 303-921-4370 |
Dr. Patricia Louise Landow, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 10613 W Dumbarton Cir, Unit D, Littleton, CO 80127 Phone: 303-904-2115 |
Linda S. Bluestein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 8091 Shaffer Pkwy, Littleton, CO 80127 Phone: 720-588-2214 Fax: 715-972-8152 |
Dr. Victor Russell Daniel, M. D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6350 S Ponds Way, Littleton, CO 80123 Phone: 303-794-8192 |
Dr. Jeanie M Schlafly, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 7386 W Clifton Ave, Littleton, CO 80128 Phone: 720-839-4296 |
News Archive
Scientists from the International Vaccine Institute (IVI) have discovered that an antigen common to most influenza viruses, and commonly referred to as matrix protein 2 (M2), when administered under the tongue could protect mice against experimental infection caused by various influenza viruses, including the highly pathogenic avian H5 virus and the pandemic H1 ("swine flu") virus.
New research conducted at Aarhus University has revealed that people who have grown up on a farm with livestock are only half as likely as their urban counterparts to develop the most common inflammatory bowel diseases: ulcerative colitis and Crohn's disease.
Researchers at the University of California, San Diego School of Medicine have discovered that hard-to-reach, drug-resistant leukemia stem cells (LSCs) that overexpress multiple pro-survival protein forms are sensitive - and thus vulnerable - to a novel cancer stem cell-targeting drug currently under development.
An MUSC Hollings Cancer Center researcher received a $3 million grant from the National Cancer Institute to study how patterns of collagens can serve as biomarkers of breast cancer risk and potentially reveal clues to what might be driving health disparities.
Cereplast, Inc., manufacturer of proprietary bio-based sustainable plastics, applauds the Food and Drug Administration (FDA) for demanding increased study of the long-term effects of Bisphenol A (BPA) exposure.
› Verified 7 days ago